---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-094557"
form_type: "8-K"
ticker: null
cik: "0001213660"
company_name: "BIMI Holdings Inc."
filed_at: "2023-12-11T23:59:59+00:00"
generated_at: "2026-06-07T14:43:24.312924+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# BIMI issues 5M shares to Chairman after Phenix Bio earns $2.5M profit target in Q2 2023

## Summary
- Phenix Bio achieved aggregate net profit of at least $2.5M in Q2 2023, triggering earnout shares.
- 5,000,000 common shares issued to Chairman Fnu Oudom on Dec 6, 2023 as earnout consideration.
- Total acquisition price for Phenix: $180K cash plus 5.27M shares; additional 5M shares issued on milestone.
- Transaction closed March 15, 2023; performance condition met in Q2 2023.

## SEC filing metadata
- accession: 0001213900-23-094557
- form_type: 8-K
- cik: 0001213660
- company_name: BIMI Holdings Inc.
- filed_at: 2023-12-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.01, 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1213660/000121390023094557/0001213900-23-094557-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1213660/000121390023094557/ea189792-8k_bimiinter.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-094557
- JSON: https://secwatch.observer/filing/0001213900-23-094557.json
- Plain text: https://secwatch.observer/filing/0001213900-23-094557.txt

## Key facts
- M&A Transactions
  BIMI Holdings Inc. completed an acquisition involving Fnu Oudom for $180,000 in cash plus 5,270,000 shares of the Company's common stock (closed 2023-03-15).
  - Action: acquisition
  - Counterparty: Fnu Oudom
  - Consideration: $180,000 in cash plus 5,270,000 shares of the Company's common stock
  - Closing: 2023-03-15
  source text: the transaction closed effective March 15, 2023 when 100% of equity interests in Phenix were transferred to the Company and the closing consideration was paid. The aggregate purchase price for the equity interests in Phenix was $180,000 in cash, which has been paid, plus 5,270,000 shares of the Company’s common stock
  evidence_url: https://www.sec.gov/Archives/edgar/data/1213660/000121390023094557/0001213900-23-094557-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.